Nextel Medical Corp. (MAJI)
OTC Markets OTCID
Price as at 30 Sept 2026, 21:00 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Nextel Medical Corp. trades at $0.01. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Nextel Medical Corp.
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its MAJI data?
Fundamentals for MAJI come from company filings and exchange data, as listed on OTC Markets OTCID; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 21:00 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for MAJI, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.